Gabapentin
- Product NDC
- 53217-284
- 11-digit product format
- 532170284
- Labeler code
- 53217
- Product ID
- 53217-284_041af629-e2da-4269-b675-7766fc40b51d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA090858
- Marketing category
- ANDA
- Marketing start
- 2011-01-29
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53217-284 | GABAPENTIN CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | Legacy NDC, 12 package rows | 20170422_633e0bbe-579d-40c6-9347-d357291708e0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 53217-284-00 | 53217028400 | 100 in 1 BOTTLE | Historical |
| 53217-284-02 | 53217028402 | 120 in 1 BOTTLE | Historical |
| 53217-284-15 | 53217028415 | 15 in 1 BOTTLE | Historical |
| 53217-284-21 | 53217028421 | 21 in 1 BOTTLE | Historical |
| 53217-284-22 | 53217028422 | 270 in 1 BOTTLE | Historical |
| 53217-284-30 | 53217028430 | 30 in 1 BOTTLE | Historical |
| 53217-284-42 | 53217028442 | 42 in 1 BOTTLE | Historical |
| 53217-284-45 | 53217028445 | 45 in 1 BOTTLE | Historical |
| 53217-284-60 | 53217028460 | 60 in 1 BOTTLE | Historical |
| 53217-284-81 | 53217028481 | 81 in 1 BOTTLE | Historical |
| 53217-284-90 | 53217028490 | 90 in 1 BOTTLE | Historical |
| 53217-284-99 | 53217028499 | 180 in 1 BOTTLE | Historical |